OptimizeRx Corporation (OPRX)
- Previous Close
8.94 - Open
8.97 - Bid 9.10 x 100
- Ask 9.19 x 100
- Day's Range
8.73 - 9.17 - 52 Week Range
6.92 - 16.65 - Volume
139,715 - Avg. Volume
122,512 - Market Cap (intraday)
166.565M - Beta (5Y Monthly) 1.01
- PE Ratio (TTM)
-- - EPS (TTM)
-1.03 - Earnings Date May 8, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
16.17
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
www.optimizerx.com135
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: OPRX
Performance Overview: OPRX
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OPRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OPRX
Valuation Measures
Market Cap
166.56M
Enterprise Value
189.54M
Trailing P/E
--
Forward P/E
26.18
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.19
Price/Book (mrq)
1.32
Enterprise Value/Revenue
2.65
Enterprise Value/EBITDA
-8.89
Financial Highlights
Profitability and Income Statement
Profit Margin
-24.56%
Return on Assets (ttm)
-5.20%
Return on Equity (ttm)
-13.90%
Revenue (ttm)
71.52M
Net Income Avi to Common (ttm)
-17.57M
Diluted EPS (ttm)
-1.03
Balance Sheet and Cash Flow
Total Cash (mrq)
13.85M
Total Debt/Equity (mrq)
29.10%
Levered Free Cash Flow (ttm)
-2.4M
Research Analysis: OPRX
Company Insights: OPRX
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: OPRX
OPRX: Lowering target price to $10.00
OPTIMIZERX CORP has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetOPRX: Lowering target price to $13.00
OPTIMIZERX CORP has an Investment Rating of SELL; a target price of $13.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetOPRX: What does Argus have to say about OPRX?
OPTIMIZERX CORP has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetOPRX: What does Argus have to say about OPRX?
OPTIMIZERX CORP has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target